---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-026092"
form_type: "8-K"
ticker: "APVO"
cik: "0001671584"
company_name: "Aptevo Therapeutics Inc."
filed_at: "2023-06-02T23:59:59+00:00"
generated_at: "2026-06-14T08:19:43.911914+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Aptevo shareholders elect Harsanyi and Kunz to board, ratify Moss Adams as auditor

## Summary
- Two directors elected: Zsolt Harsanyi received 967,133 for, 343,098 withheld; Barbara Lopez Kunz received 716,175 for, 594,056 withheld.
- Ratification of Moss Adams LLP as independent auditor for FY2023: 3,581,428 for, 276,500 against, 19,109 abstain.
- Non-binding advisory vote on named executive officer compensation: 969,344 for, 332,792 against, 8,095 abstain, with 2,566,806 broker non-votes.
- All three proposals passed at the June 2, 2023 Annual Meeting.

## SEC filing metadata
- accession: 0000950170-23-026092
- form_type: 8-K
- ticker: APVO
- cik: 0001671584
- company_name: Aptevo Therapeutics Inc.
- filed_at: 2023-06-02T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1671584/000095017023026092/0000950170-23-026092-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1671584/000095017023026092/apvo-20230602.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-026092
- JSON: https://secwatch.observer/filing/0000950170-23-026092.json
- Plain text: https://secwatch.observer/filing/0000950170-23-026092.txt

## Key facts
- Shareholder Votes
  Aptevo Therapeutics Inc. shareholders approved Election of Directors at the 2023-06-02 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-02
  source text: The following two nominees, each of whom were named in the Proxy Statement, were elected to serve on the Board of Directors to hold office until the 2026 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified, based on the following votes: FOR WITHHELD BROKER NON-VOTES Zsolt Harsanyi, Ph.D. 967,133 343,098 2,566,806 Barbara Lopez Kunz 716,175 594,056 2,566,806
  evidence_url: https://www.sec.gov/Archives/edgar/data/1671584/000095017023026092/0000950170-23-026092-index.htm
- Shareholder Votes
  Aptevo Therapeutics Inc. shareholders approved Approval, on a non-binding advisory basis, of the Company's named executive officer compensation as disclosed in the Proxy Statement at the 2023-06-02 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-06-02
  source text: FOR AGAINST ABSTAIN BROKER NON-VOTES 969,344 332,792 8,095 2,566,806
  evidence_url: https://www.sec.gov/Archives/edgar/data/1671584/000095017023026092/0000950170-23-026092-index.htm
- Shareholder Votes
  Aptevo Therapeutics Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm for 2023 at the 2023-06-02 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-02
  source text: FOR AGAINST ABSTAIN 3,581,428 276,500 19,109
  evidence_url: https://www.sec.gov/Archives/edgar/data/1671584/000095017023026092/0000950170-23-026092-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.